Health Care Systems

Global TB deaths are increasing. CGD and OHE set out a “Market-Driven, Value-Based, Advance Commitment (MVAC)” that would create and guarantee a market for a breakthrough short, universal TB regimen tackling MDR strains. An earlier 1998 OHE publication argued for the UK to move from...

Since 1984, the UK's second Wednesday of each March is NO SMOKING DAY (NSD). The NSD aims to encourage smokers who want to quit. In 2022, NSD falls on the 9th of March and has the slogan "Today is the Day". 

On the occasion of the 2022 NSD, a reflection on where the UK is regarding...

As US policymakers consider the potential implications of the drug pricing reforms contained within the Build Back Better Act, OHE releases a critique of the Congressional Budget Office scoring, demonstrating that the estimates are highly uncertain and policymakers should exercise caution when relying upon them.

OHE publishes a research report sponsored by CRUK on the practical considerations for outcome-based payment in the NHS

Around 10% of people in the United Kingdom (UK) have chronic kidney disease (CKD) according to Kidney Care UK. While CKD can be managed through diet and lifestyle changes in most patients, around 10% of them will suffer renal failure, where their kidneys no longer function well enough to support a normal, healthy life. Untreated, renal failure will ultimately lead to death.

Why is the measurement of efficiency in health care so important, but equally challenging? And why is it especially so in primary care? This blog provides an overview of these well-known issues, and offers a glimpse into the results of a new OHE analysis of approaches to measure efficiency in primary care and recommendations for future research.

This blog summarises an initiative taken by more than 300 health economists and experts in support of the creation of an independent health technology assessment agency in Spain.

Case studies explored more and less successful practices when delivering healthcare across four priority areas (screening, disease management and standardised patient pathways, rational use of medicines and healthcare associated infections). Results were used to simulate cost-savings and patient outcomes that could potentially be realised with improvements in efficiency across the European Union of 27 countries and the United Kingdom.

In a recently published OHE Consulting Report, we report the long-term return on investment (ROI) per £1 spent on various vaccination programmes from the perspective of the UK government. In this blog, we discuss how discounting affects the estimated long-term value of vaccination and, thus, decision-makers’ investment decisions.

On the occasion of Adam Wagstaff’s death, Professor Tony Culyer reflects on his vast legacy to health economics, from Tony’s perspective of having been Adam’s PhD supervisor as well as a friend and collaborator.

Pages

Subscribe to RSS - Health Care Systems